Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: sites default files B Calingaert ICPEPoster pdf
Benefit-Risk Assessment Do your product’s benefits outweigh its potential risks? More importantly, do you have the right data to credibly demonstrate this to regulators, payers, physicians, and patients? You can rely on our experienced team to help you …
Publication Management and Medical Writing Publications are critical for the dissemination of your scientific and medical research. When you partner with us on your research projects, our expert team of medical writers can provide you with total …
Knowledgebase - ICER Evaluations Image Image Image Knowledgebase KB Image Image KB …
FDA and AMCP Guidance on Pre-Approval Submissions and the Continuous Process of Dossier Development Share on: December 20, 2019 Article contributed by: Shahnaz Khan, MPH , Executive Director, Market Access and Outcomes Strategy at RTI Health Solutions …
… psychosis in the United States. Rao S, Forns J, Danysh HE, Calingaert B , Dempsey C, Aquilina T, Pathak S, Anthony MS, Layton JB . …
Added support for your real-world evidence needs Share on: October 28, 2019 New office in Lyon, France, enhances our capabilities in real-world evidence generation Real-world evidence plays a critical role in product strategy and healthcare …
Locations Image click to see larger version of map With offices located around the globe, RTI-HS is truly an international and diverse organization. Working alongside a multinational and multidisciplinary team of colleagues will afford you a unique …
JCA Evidence Preparation and Support For successful marketing authorization submissions, you need compelling and robust evidence to support your product. We have an experienced team that can provide high quality, unbiased research that will stand up to …
… of 2027, followed by 15 additional Medicare Part D or Part B drugs for IPAY 2028. The plan is to choose 20 drugs for … Drugs with total spending under Medicare Part D and Part B combined of less than $200 million Plasma-derived products …
JCA Development and Support We can be your expert partner for education and guidance throughout the whole development process including JCA impact on your product pipeline. We can help you with: JCA dossier and evidence refinement Post-submission support …